1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Estonia Pharmaceuticals and Healthcare Report Q1 2016

Estonia Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 87 pages

Includes 3 FREE quarterly updates

BMI View: Estonian pharmaceutical sales posted larger than expected growth in 2014, but we expectpharmaceutical sales growth to have decelerated in 2015 as the impact of the Russian slowdown moderateseconomic activity. With Estonia seeing external tailwinds from the eurozone and Scandinavian countries,we expect pharmaceutical sales to stay largely flat in 2016 and beyond. Western-Russian relations willcontinue to present downside risk to our forecasts.

Headline Expenditure Projections

- Pharmaceuticals: Sales will rise from EUR292mn (USD391mn) in 2014 to EUR310mn (USD341mn) in2015, up 6.1% in local currency terms and down 12.9% in US dollar terms. Forecast stayed flat from lastquarter.

- Healthcare: Spending will rise from EUR1.15bn (USD1.54bn) in 2014 to EUR1.22bn (USD1.34bn) in2015, up 6.0% in local currency terms and down 13.0% in US dollar terms. Forecast stayed flat from lastquarter.

Table Of Contents

Estonia Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Estonia 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Estonia 2011-2019) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Estonia 2011-2019) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Estonia 2011-2019) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Estonia 2011-2019) 16
Prescription Drug Market Forecast 17
Table: Leading Anatomical Therapeutic Chemical (ATC) Groups By Pharmaceutical Sales, 2004-2010 (%) 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Estonia 2011-2019) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Estonia 2011-2019) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Estonia 2011-2019) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Estonia 2011-2019) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Estonia 2013-2019) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Estonia 2013-2019) 30
Pharmaceuticals Risk/Reward Index 31
Central And Eastern Europe Risk/Reward Index - Q1 2016 31
Estonia Risk/Reward Index 38
Rewards 38
Risks 38
Regulatory Review 40
Table: Key Health Insurance Indicators, 2007-2011 46
Table: Expenditure By Reimbursed Prescription Medicinal Products, 2005-2010 (EEK '000) 47
Market Overview 49
Healthcare Sector 50
Healthcare Reform 51
Healthcare Provision 52
Table: Healthcare Resources (Estonia 2009-2014) 52
Table: Healthcare Personnel (Estonia 2009-2014) 52
Table: Healthcare Activity (Estonia 2009-2014) 53
Healthcare Funding 53
Table: HIF Healthcare Expenditure, 2006-2011 (EURmn) 54
Healthcare Insurance 54
Table: Reimbursement Spending By Key Therapeutic Area, 2010-2011 (EURmn) 55
Table: Medicinal Products Reimbursed For Insured Patients, 2009-2011 (EURmn) 57
Healthcare Tourism 57
Research And Development 57
Table: Members Of EBio, 2011 58
Clinical Trials 60
Table: Number Of Clinical Trials, 1991-2011 61
Table: Leading Causes Of Death, 2005-2010 63
Competitive Landscape 65
Table: Members Of The Association Of International Pharmaceutical Manufacturers In Estonia 66
Table: Table: Multinational Market Activity 66
Generic Drugmakers 67
Pharmaceutical Distribution 68
Pharmaceutical Retail Sector 69
Table: Pharmacies And Pharmacy Market Ratios, 2004-2009 69
Company Profile 72
Grindeks (incorporating Tallinn Pharmaceutical Plant) 72
Demographic Forecast 76
Table: Population Headline Indicators (Estonia 1990-2025) 77
Table: Key Population Ratios (Estonia 1990-2025) 77
Table: Urban/Rural Population and Life Expectancy (Estonia 1990-2025) 78
Table: Population By Age Group (Estonia 1990-2025) 78
Table: Population By Age Group % (Estonia 1990-2025) 79
Glossary 81
Methodology 83
Pharmaceutical Expenditure Forecast Model 83
Healthcare Expenditure Forecast Model 83
Notes On Methodology 84
Risk/Reward Index Methodology 85
Index Overview 86
Table: Pharmaceutical Risk/Reward Index Indicators 86
Indicator Weightings 87

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.